grant

Molecular understanding of combination epigenetic therapy in MLL-fusion leukaemia [ 2014 - 2017 ]

Also known as: Novel combinations of targeted therapy for the treatment of MLL leukaemia

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1066545]

Researchers: Prof Mark Dawson (Principal investigator)

Brief description The poor prognosis conferred by chromosome breaks involving the MLL gene in acute leukaemia has not significantly changed in over twenty years. This fact highlights the urgent need to identify and develop novel therapeutic agents for this disease. This project will aim to understand the mechanisms leading to the initiation and maintenance of this aggressive disease. We will then use these insights to develop a rational combination of therapeutic agents.

Funding Amount $AUD 624,660.47

Funding Scheme Project Grants

Notes New Investigator Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857